Advertisement

Topics

Accelerator Corp Company Profile

01:10 EST 20th November 2017 | BioPortfolio

VieVax Corp. is focused on commercializing a novel approach to vaccine development that is designed to overcome the limitations of existing vaccine technologies. These technologies, largely unchanged and unimproved for the past half-century, have consistently fallen short in addressing a number of critical issues, including: the spread of serious emerging infectious diseases, the emergence of treatment-resistant strains of infectious pathogens, robust and reliable manufacturing, the growing threat of bioterrorism employing infectious pathogens, and, a failure to evelop vaccines against infectious agents such as HIV.

Location

1616 Eastlake Ave. E.
Seattle
Washington
98102
United States of America

Contact

Phone: 206.957.7300
Fax: 206.957.7399
Email: info@acceleratorcorp.com


News Articles [202 Associated News Articles listed on BioPortfolio]

Illumina Accelerator Sees ‘Huge Impact in Genomics’ in New Startups

Genomics startups are increasing in number and quality, so much so that three-year-old Illumina Accelerator has expanded with its latest class to accommodate five of them. Xconomy got an early look at...

Cedars-Sinai Healthcare Accelerator Unveils Third Class of 10 Digital Health Startups

Techstars Healthcare Accelerator, in partnership with Cedars-Sinai, today announced the 10 digital health startups selected to participate in its third class. From artificial intelligence to new devic...

Novartis to acquire Advanced Accelerator Applications for oncology portfolio

Novartis has entered a memorandum of understanding with Advanced Accelerator Applications (AAA) under which Novartis intends to commence a tender offer for 100% of the share capital of AAA subject to ...

Novartis to Expand Oncology Business by Acquiring Advanced Accelerator Applications for $3.9 Billion

Basel, October 30, 2017 – Novartis announced today, that it has entered a memorandum of understanding with Advanced Accelerator Applications (AAA) under which Novartis intends to commence a ten...

Accelerator i Lund kör igen

Health2B är en accelerator för tidiga bolag inom teknik och hälsa, och genomförs i life science-inkubatorn Smiles regi i Lund. Nu startar fjärde omgången.

The Right Mix Gives Your Digital Health Accelerator A Competitive Edge

Everyone's building an accelerator, but they just might be building it the wrong way.

Dixie-Lee Esseltine joins HBS Kraft Precision Medicine Accelerator

Dr. Dixie-Lee Esseltine, formerly the Vice President of Global Clinical Development at Takeda Pharmaceuticals, recently joined the Harvard Business School’s (HBS) Kraft Precision Medicine Accelerato...

NHS medtech accelerator unveils first award winners

A blood sampling patient safety solution, a novel headset for children with long-term 'glue ear', and a project to develop a new coating to prevent prostheses infection have won funding from an NHS in...

PubMed Articles [54 Associated PubMed Articles listed on BioPortfolio]

Preliminary Determination of Activation Products for a Varian Truebeam Linear Accelerator.

Medical linear accelerators used to treat various forms of cancers are operated at a number of different energies. A by-product of the high-energy photons produced by accelerators is activation of com...

Hemin as electrochemically regenerable co-reaction accelerator for construction of an ultrasensitive PTCA-based electrochemiluminescent aptasensor.

In this work, hemin was firstly used as electrochemically regenerable co-reaction accelerator for signal amplification to develop an ultrasensitive aptasensor for Aflatoxin M1 (AFM1) detection. Initia...

A single-source photon source model of a linear accelerator for Monte Carlo dose calculation.

To introduce a new method of deriving a virtual source model (VSM) of a linear accelerator photon beam from a phase space file (PSF) for Monte Carlo (MC) dose calculation.

Ethnic differences in association of high body mass index with early onset of Type 1 diabetes - Arab ethnicity as case study.

The "accelerator hypothesis" predicts early onset of Type 1 diabetes (T1D) in heavier children. Studies testing direction of correlation between body mass index (BMI) and age at onset of T1D in differ...

Technical Note: Comparison of peripheral patient dose from MR-guided (60) Co therapy and 6MV linear accelerator IGRT.

The use of X-ray imaging in radiation therapy can give a substantial dose to the patient. A Cobalt machine combined with an magnetic resonance imaging (MRI) was recently introduced to clinical work. O...

Clinical Trials [17 Associated Clinical Trials listed on BioPortfolio]

First-In Man (FIM) Study MR-Linac

Investigational device is the Magnetic resonance imager linear accelerator. Five (5) patients with bone metastases will be treated with palliative intention in this study. The goal is to c...

Evaluation of Capsulotomy by Linear Accelerator Radiosurgery in Severe and Refractory Obsessive-compulsive Disorder

The aim of this study is to evaluate, through a pilot study with about ten cases, if bilateral ventral capsulotomy by linear accelerator enable modification of obsessive-compulsive symptom...

Stereotactic Body Radio Therapy (SBRT) for Early-Stage Non Small Cell Lung Cancer (NSCLC)

The purpose of this study is to evaluate local disease control after 2 years in patients with non-metastatic, non-operated non-small-cell lung cancer treated by radiotherapy. Eligible pat...

Autoimmune Diabetes Accelerator Prevention Trial

The autoimmune diabetes ACCELERATOR PREVENTION TRIAL (adAPT) is based on the accelerator hypothesis. The trial is designed to establish whether metformin, an oral hypoglycaemic agent that ...

Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer

This study will assess the efficacy of treating locally advanced pancreatic cancer using a linear accelerator designed for image-guided radiotherapy

Companies [91 Associated Companies listed on BioPortfolio]

Cydan

Cydan is an orphan drug accelerator that identifies and de-risks assets with therapeutic and commercial potential. The accelerator’s model evaluates programs for treating rar...

Triphase Accelerator Corporation

Triphase Accelerator is a private drug development company with a primary focus on oncology and with operations in Toronto and San Diego. Triphase Accelerator is dedicated to adva...

SKTA Innopartners

SKTA Innovation Accelerator is a different kind of accelerator based in Silicon Valley. We seed core technology startups by matching entrepreneurs with Strategic Partners committe...

Cydan, LLC

Cydan is an orphan drug accelerator that identifies and de-risks assets with therapeutic and commercial potential. The accelerator’s model evaluates programs for treating rar...

AgTech Accelerator

AgTech Accelerator, established in 2016 in Research Triangle Park, is a venture development organization focused on discovering and developing emerging agricultural technology and...

More Information about "Accelerator Corp" on BioPortfolio

We have published hundreds of Accelerator Corp news stories on BioPortfolio along with dozens of Accelerator Corp Clinical Trials and PubMed Articles about Accelerator Corp for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Accelerator Corp Companies in our database. You can also find out about relevant Accelerator Corp Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Vaccine
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Corporate Database Quicklinks



Searches Linking to this Company Record